Dr. (Prof.) Vijay Patil

CO-FOUNDER, SUNACT
SPECIALISED IN ADVANCED CANCER THERAPIES

Empowering patients

Leading Cancer Care

Dr. (Prof.) Vijay Patil is a distinguished medical oncologist with over 2 decades of clinical and research experience, specializing in the management of solid tumors and the development of next-generation cancer therapies. He has authored more than 750+ peer-reviewed publications in leading international journals, including the Journal of Clinical Oncology, The Lancet Global Health, Oral Oncology, Cancer, Cancer Cell, and ASCO publications.

He completed his MBBS from Seth Gordhandas Sunderdas Medical College (GSMC) & KEM Hospital, Mumbai (2006), followed by an MD in Radiotherapy from PGIMER, Chandigarh (2009) with the Kataria Gold Medal, and earned his DM in Medical Oncology from Tata Memorial Centre, Mumbai, in 2013 with a Gold Medal.

Through his clinical expertise and research leadership at SunAct, Dr. (Prof.) Patil continues to contribute to advancements in oncology and strives to improve outcomes for patients worldwide.

M. B. B. S. (Gold Medal)

FEB 2006

MEDICINE, SURGERY AND ALLIED SUBJECTS
GSMC & KEMH, MUMBAI, INDIA

M. D. (Gold Medal)

JULY 2009

RADIOTHERAPY
PGIMER , CHANDIGARH, INDIA

D. M. (Gold Medal)

JULY 2013

MEDICAL ONCOLOGY
TATA MEMORIAL CENTER, MUMBAI, INDIA

Clinical Excellence Across Cancer Types

Dr. (Prof.) Vijay Patil’s clinical expertise and research focus on developing innovative, evidence-based cancer treatments that are both highly effective and accessible. His work has consistently bridged the gap between cutting-edge oncology and practical, affordable care. Through rigorous clinical trials published in the world’s leading medical journals, he has established new standards of care that have improved outcomes for cancer patients.

Head & Neck Cancer

Pioneered low-cost immunotherapy and oral metronomic regimens that reduced treatment costs by over 90% while improving survival and quality of life.

Lung Cancer (Thoracic Tumors)

Established oral-targeted therapy combinations now recognized as international standard guidelines for EGFR-mutated lung cancers.

Neuro-Oncology (Brain Tumors)

Innovated video follow-ups and repurposed affordable medications for glioblastoma treatment, while leading multidisciplinary brain metastasis care.

Uro-Oncology

Established effective chemotherapy protocols for penile cancer and validated targeted therapies for kidney and prostate cancers.

Gastrointestinal Cancers

Developed comprehensive treatment protocols spanning chemotherapy, targeted therapy, and immunotherapy across all GI tumor stages.

Breast & Gynecological Cancers

Implemented internationally recognized treatment standards ensuring world-class care for women’s cancers.

Patient Stories

In their own words.

Stories of resilience, trust, and transformation, words that remind us of the profound impact we strive to make, one life at a time.

Trusted by Those We Treat

Real stories from patients and families who placed their trust in our care.